Re: Efficacy and safety of regorafenib in patients with metastatic or locally-advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study. (November 2021) - Zhou, Deborah; Connolly, Elizabeth; Strach, Madeleine; Bhadri, Vivek; Grimison, Peter